World Health Organization. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death .Accessed Dec 2020.

Roth GA, Mensah GA, Johnson CO et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010

Article  PubMed  PubMed Central  Google Scholar 

NCD Countdown 2030 collaborators (2020). NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. Lancet (London, England), 396(10255):918–934. https://doi.org/10.1016/S0140-6736(20)31761-X

Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253(8):2769–2776

Article  CAS  PubMed  Google Scholar 

Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212(4500):1279–1281. https://doi.org/10.1126/science.6262917

Article  CAS  PubMed  Google Scholar 

Schutte AE, Conti E, Mels CM et al (2016) Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a black population: a five-year prospective study. Eur J Prev Cardiol 23(16):1690–1699. https://doi.org/10.1177/2047487316661436

Article  PubMed  Google Scholar 

Sun J, Axelsson J, Machowska A et al (2016) Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol 11(7):1163–1172. https://doi.org/10.2215/cjn.10441015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hinojosa-Amaya JM, Varlamov EV, Yedinak CG et al (2021) Echocardiographic findings in acromegaly: prevalence of concentric left ventricular remodeling in a large single-center cohort. J Endocrinol Invest 44(12):2665–2674. https://doi.org/10.1007/s40618-021-01579-4

Article  CAS  PubMed  Google Scholar 

Parolin M, Dassie F, Vettor R, Steeds RP, Maffei P (2021) Electrophysiological features in acromegaly: re-thinking the arrhythmic risk? J Endocrinol Invest 44(2):209–221. https://doi.org/10.1007/s40618-020-01343-0

Article  CAS  PubMed  Google Scholar 

Vasan RS, Sullivan LM, D’Agostino RB et al (2003) Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham heart study. Ann Intern Med 139(8):642–648. https://doi.org/10.7326/0003-4819-139-8-200310210-00007

Article  CAS  PubMed  Google Scholar 

Bleumink GS, Rietveld I, Janssen JA et al (2004) Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam study). Am J Cardiol 94(3):384–386. https://doi.org/10.1016/j.amjcard.2004.04.044

Article  CAS  PubMed  Google Scholar 

van Bunderen CC, van Nieuwpoort IC, van Schoor NM, Deeg DJ, Lips P, Drent ML (2010) The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. J Clin Endocrinol Metab 95(10):4616–4624. https://doi.org/10.1210/jc.2010-0940

Article  CAS  PubMed  Google Scholar 

Ricketts SL, Rensing KL, Holly JM et al (2011) Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease. Int J Mol Epidemiol Genet 2(3):261–285

CAS  PubMed  PubMed Central  Google Scholar 

Friedrich N, Haring R, Nauck M et al (2009) Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 94(5):1732–1739. https://doi.org/10.1210/jc.2008-2138

Article  CAS  PubMed  Google Scholar 

Jing Z, Hou X, Wang Y et al (2015) Association between insulin-like growth factor-1 and cardiovascular disease risk: evidence from a meta-analysis. Int J Cardiol 198:1–5. https://doi.org/10.1016/j.ijcard.2015.06.114

Article  PubMed  Google Scholar 

Kaplan RC, McGinn AP, Pollak MN et al (2007) Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 92(4):1319–1325. https://doi.org/10.1210/jc.2006-1631

Article  CAS  PubMed  Google Scholar 

Saber H, Himali JJ, Beiser AS et al (2017) Serum insulin-like growth factor 1 and the risk of ischemic stroke: the Framingham study. Stroke 48(7):1760–1765. https://doi.org/10.1161/strokeaha.116.016563

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaplan RC, Strizich G, Aneke-Nash C et al (2017) Insulinlike growth factor binding protein-1 and ghrelin predict health outcomes among older adults: cardiovascular health study cohort. J Clin Endocrinol Metab 102(1):267–278. https://doi.org/10.1210/jc.2016-2779

Article  PubMed  Google Scholar 

Ruidavets JB, Luc G, Machez E et al (2011) Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis 218(2):464–469

Article  CAS  PubMed  Google Scholar 

Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106(8):939–944. https://doi.org/10.1161/01.cir.0000027563.44593.cc

Article  CAS  PubMed  Google Scholar 

Saydah S, Graubard B, Ballard-Barbash R, Berrigan D (2007) Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 166(5):518–526. https://doi.org/10.1093/aje/kwm124

Article  PubMed  Google Scholar 

Schneider HJ, Wallaschofski H, Völzke H et al (2012) Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction. PLoS ONE 7(3):e33084. https://doi.org/10.1371/journal.pone.0033084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study. J Clin Endocrinol Metab 89(1):114–120. https://doi.org/10.1210/jc.2003-030967

Article  CAS  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Article  PubMed  PubMed Central  Google Scholar 

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z

Article  PubMed  Google Scholar 

Ohlsson C, Mohan S, Sjogren K et al (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30(5):494–535. https://doi.org/10.1210/er.2009-0010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73. https://doi.org/10.1093/aje/kwr265

Article  PubMed  Google Scholar 

Saber H, Himali JJ, Beiser A, et al. High serum insulin-like growth factor 1 is associated with lower risk of ischemic stroke: The framingham heart study. Stroke Conference: American Heart Association/American Stroke Association. 2015;46(1).

Hamling J, Lee P, Weitkunat R, Ambühl M (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27(7):954–970. https://doi.org/10.1002/sim.3013

Article  PubMed  Google Scholar 

Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 167(9):1017–1026. https://doi.org/10.1093/aje/kwn005

Article  PubMed  Google Scholar 

Greenland S (1995) Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6(4):356–365. https://doi.org/10.1097/00001648-199507000-00005

Article  CAS  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Zhang D, Liu Y et al (2017) Dose-response association between physical activity and incident hypertension: a systematic review and meta-analysis of cohort studies. Hypertension 69(5):813–820. https://doi.org/10.1161/hypertensionaha.116.08994 (Dallas, Tex : 1979)

Article  CAS  PubMed  Google Scholar 

Cai Z, Fan X (2020) A comparison of fixed-effects and random-effects models for multivariate meta-analysis using an SEM approach. Multivariate Behav Res 55(6):839–854. https://doi.org/10.1080/00273171.2019.1689348

Article  PubMed  Google Scholar 

Allison PD. Fixed Effects Regression Models. SAGE. 2006

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

Article  CAS  PubMed  Google Scholar 

Saber H, Himali JJ, Beiser AS et al (2017) Serum insulin-like growth factor 1 and the risk of ischemic stroke. Stroke 48(7):1760–1765

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obradovic M, Zafirovic S, Soskic S et al (2019) Effects of IGF-1 on the cardiovascular system. Curr Pharm Des 25(35):3715–3725. https://doi.org/10.2174/1381612825666191106091507

Article  CAS